C-Path Using Rosetta's Resolver in Predictive Safety Testing Consortium | GenomeWeb
NEW YORK (GenomeWeb News) – The Critical Path Institute will use Rosetta Biosoftware’s Resolver system, Rosetta said today.
 
C-Path will use the software for data management and analysis in its Predictive Safety Testing Consortium, which is a collection of pharmaceutical companies that work with C-Path to share information that may help improve drug safety.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.